Viewing Study NCT00495092


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-01-26 @ 12:06 PM
Study NCT ID: NCT00495092
Status: COMPLETED
Last Update Posted: 2012-03-01
First Post: 2007-06-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Organization:

Study Overview

Official Title: Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
Status: COMPLETED
Status Verified Date: 2012-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to assess the efficacy of caffeine compared to placebo in detoxifying cocaine dependent patients. Caffeine potentiation with biperiden will be also studied.

108 with cocaine dependence will be randomized to receive caffeine (300 - 1200 mg t.i.d.) plus biperidene (8 mg b.i.d.) or caffeine (300 - 1200 mg t.i.d.) with placebo or placebo during 6 months.

Primary efficacy outcomes will be 1) patient comfort assessed with abstinence symptomatology, craving for cocaine and mental status during detoxifying period, 2) study retention and 3) cocaine use.

Brain dopamine system will be assessed thru IBZM-SPECT and the apomorphine test.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
INT/71525/2003 None None View